befunolol has been researched along with propranolol in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Inoue, H; Maruyama, Y; Masumoto, S | 1 |
Awaji, T; Inoue, M; Maruyama, Y; Takeo, S | 1 |
Koike, K; Takayanagi, I | 2 |
Koike, K; Nakagoshi, A; Takayanagi, I | 1 |
Furusho, Y; Ihara, S; Itaya, K; Kumagai, E; Matoba, T; Midorikawa, K; Miki, N; Terasawa, M; Toshima, H | 1 |
Ebihara, A; Kawahara, K; Ofuji, T; Oka, T; Tawara, K | 1 |
Honda, Y; Matsuda, H; Matsumura, M; Yoshimura, N | 1 |
Hirun, N; Kraisit, P; Limmatvapirat, S; Limpamanoch, P | 1 |
9 other study(ies) available for befunolol and propranolol
Article | Year |
---|---|
[The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Benzofurans; Blood Pressure; Dogs; Epinephrine; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Ouabain; Propanolamines; Propranolol; Rats; Uterus | 1979 |
Protective effects of befunolol on hypoxic respiration-induced alterations in myocardial energy metabolism of rats.
Topics: Adenosine Triphosphate; Animals; Blood Gas Analysis; Blood Pressure; Energy Metabolism; Heart Rate; Lactates; Male; Methyltyrosines; Myocardium; Oxygen Consumption; Phosphocreatine; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Reserpine | 1991 |
A beta-adrenoceptor blocking agent, befunolol as a partial agonist in isolated organs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Intestines; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth; Myocardial Contraction; Propanolamines; Propranolol; Trachea | 1985 |
A beta-adrenergic partial agonist (befunolol) discriminates two different affinity sites.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Carteolol; Cecum; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1986 |
Interactions of some partial agonists with high and low affinity binding sites in beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Binding Sites; Carteolol; Cecum; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1987 |
Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Benzofurans; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Oxygen Consumption; Physical Exertion; Propanolamines; Propranolol; Time Factors | 1980 |
Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Exercise Test; Heart Rate; Humans; Kinetics; Male; Physical Exertion; Propanolamines; Propranolol | 1982 |
The retinal toxicity of befunolol and other adrenergic beta-blocking agents: inhibition of phagocytic activity of cultured retinal pigment epithelial cells.
Topics: Adrenergic beta-Antagonists; Animals; Cells, Cultured; Chick Embryo; Phagocytosis; Pigment Epithelium of Eye; Pilocarpine; Propanolamines; Propranolol; Timolol | 1983 |
Design and development of 3D-printed bento box model for controlled drug release of propranolol HCl following pharmacopeia dissolution guidelines.
Topics: Drug Liberation; Printing, Three-Dimensional; Propranolol; Solubility; Tablets; Technology, Pharmaceutical | 2022 |